info@scopepharmachemplus.com
+91-8983531655WhatsApp : +91-8983531655
Compare
RFQ Cart
SCOPE Pharmachem plus LLP
ProductsServicesClients
Help

Scope Pharmachem

Loading Scope Pharmachem Plus...

SCOPE Pharmachem plus LLP

Scope Pharmachem Plus LLP is a reliable contract research organization (CRO) specialized in the custom synthesis of pharmacopeial & non-pharmacopeial reference standards, working standards, drug metabolites, glucuronides, and nitrosamine impurities for global pharmaceutical quality assurance.

GLP Quality & Certified COA Standards
Connect With Us

Company & Links

  • About Us
  • Board of Directors
  • Synthesis Services
  • Clients & Partners
  • Contact & RFQ

Product Categories

  • API Impurity Standards
  • Working Reference Standards
  • Isotope Labeled Compounds
  • Glucuronide Metabolites
  • Nitrosamines & NDSRIs

Direct Support

Inquiries & Quotations:
info@scopepharmachemplus.com
Direct Helpline:
+91-8983531655+91-976836041
Facility Location:
Plot No. A-66, Industrial Estate Society, Kopargaon, Ahmednagar, Maharashtra, India, PIN - 423601
Operating Hours:
Mon – Sat: 9:00 AM – 5:00 PM IST

© 2026 Scope Pharmachem Plus LLP. All Rights Reserved.

Privacy PolicyTerms & ConditionsSitemap
Glimepiride Impurity 3 (CAS 119043-16-2) | Scope Pharmachem Reference Standards
ABCDEFGHIJKLMNOPQRSTUVWXYZ
Home/Pharmaceutical Reference Standards/Pharmaceutical Reference Standards/Glimepiride Impurity 3

Glimepiride Impurity 3

Glimepiride Impurity 3
CAT No:CL-G008022
CAS No:119043-16-2
Mol. F:C16H19ClN2O4S
Mol. Wt.:370.8
Chemical Name:4-(2-(3-Ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)benzenesulfonyl chloride
Purity:>99.0%
SMILES:O=S(C1=CC=C(CCNC(N2C(C(CC)=C(C)C2)=O)=O)C=C1)(Cl)=O
Inventory Status:In Stock
Storage Conditions:Store at 2°C - 8°C
Enquire on WhatsApp
Origin: India • Standard Dossier Available

This impurity is related to Glimepiride Impurity 3 and is provided with comprehensive characterization data in accordance with international regulatory guidelines.

Suitable for analytical method development (AMD), analytical method validation (AMV), Quality Control (QC) release testing, Abbreviated New Drug Applications (ANDA), DMF filing, and commercial production batch release.

Standard Analytical Dossier Included:
  • Certified Certificate of Analysis (COA) with quantitative purity determination
  • High-Performance Liquid Chromatography (HPLC) chromatogram
  • Proton Nuclear Magnetic Resonance (1H-NMR) spectral confirmation
  • Mass Spectrometry (MS) molecular confirmation

Related Impurity Standards of Pharmaceutical Reference Standards

View All Standards →
Avapritinib Impurity 5

Avapritinib Impurity 5

Cat. No:CL-A155006
CAS No:1703793-18-3
Mol. F:C25H24FN9O
Mol. Wt:485.5
Inv. Status:In Stock
Atripla

Atripla

Cat. No:CL-A076001
CAS No:731772-50-2
Mol. F:C14H9ClF3NO2 : C8H10FN3O3S : C19H30N5O10P : C4H4O4
Mol. Wt:315.2
Inv. Status:Out of Stock
Product Not Available Temporarily
Atomoxetine Impurity 3

Atomoxetine Impurity 3

Cat. No:CL-A036022
CAS No:93982-97-9
Mol. F:C24H25NO3
Mol. Wt:375.5
Inv. Status:In Stock
Atazanavir R,R,S,R-Diastereomer

Atazanavir R,R,S,R-Diastereomer

Cat. No:CL-A009047
CAS No:NA
Mol. F:C38H52N6O7
Mol. Wt:704.9
Inv. Status:In Stock
Atazanavir R,S,R,R-Diastereomer

Atazanavir R,S,R,R-Diastereomer

Cat. No:CL-A009049
CAS No:NA
Mol. F:C38H52N6O7
Mol. Wt:704.9
Inv. Status:In Stock
Azacitidine Monophosphate

Azacitidine Monophosphate

Cat. No:CL-A039007
CAS No:2226-72-4
Mol. F:C8H13N4O8P
Mol. Wt:324.2
Inv. Status:In Stock